chr16-426368-C-A
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_014700.4(RAB11FIP3):c.362C>A(p.Pro121Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000162 in 1,544,876 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_014700.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
RAB11FIP3 | NM_014700.4 | c.362C>A | p.Pro121Gln | missense_variant | 1/14 | ENST00000262305.9 | NP_055515.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
RAB11FIP3 | ENST00000262305.9 | c.362C>A | p.Pro121Gln | missense_variant | 1/14 | 1 | NM_014700.4 | ENSP00000262305 | ||
RAB11FIP3 | ENST00000434585.6 | c.362C>A | p.Pro121Gln | missense_variant | 1/15 | 5 | ENSP00000399644 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0000197 AC: 3AN: 151936Hom.: 0 Cov.: 31
GnomAD4 exome AF: 0.0000158 AC: 22AN: 1392940Hom.: 0 Cov.: 33 AF XY: 0.0000131 AC XY: 9AN XY: 688972
GnomAD4 genome AF: 0.0000197 AC: 3AN: 151936Hom.: 0 Cov.: 31 AF XY: 0.00 AC XY: 0AN XY: 74214
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Dec 27, 2022 | The c.362C>A (p.P121Q) alteration is located in exon 1 (coding exon 1) of the RAB11FIP3 gene. This alteration results from a C to A substitution at nucleotide position 362, causing the proline (P) at amino acid position 121 to be replaced by a glutamine (Q). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at